Currently, Douglas Love is President, Chief Executive Officer & Director at Annexon, Inc.

In his past career Mr. Love occupied the position of Associate at Orrick, Herrington & Sutcliffe LLP, Corporate Counsel at Amgen, Inc., Head-Operations & Strategic Alliances at Elan Pharmaceuticals, LLC and Corporate Counsel at Genentech, Inc.

Mr. Love received a graduate degree from Mcgeorge School of Law and an undergraduate degree from the University of Southern California.